INSMED Inc

INSM · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $28.8B · 1,664 employees
208
SEC Filings
$127.28
Close 2026-09-10
1,664
Employees

Business Summary

Insmed is a global biopharmaceutical company developing and commercializing therapies for serious diseases across three therapeutic areas: Respiratory, Immunology & Inflammation, and Neuro & Other Rare. Its two commercial products are ARIKAYCE (amikacin liposome inhalation suspension) for MAC lung disease, approved in the US, EU, and Japan, and BRINSUPRI (brensocatib tablets) for non-cystic fibrosis bronchiectasis, approved in the US and EU in 2025. Its pipeline includes TPIP, INS1148, and gene therapies INS1201 and INS1202.

Latest Stock Quote

INSM 2026-09-10 $127.28 O:$127.22 H:$128.85 L:$124.29 Vol:2.6M VWAP:$127.2433
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-08-09

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-192025-12-310001104506-26-000009EDGAR91K words
2025-02-202024-12-310001104506-25-000009EDGAR90K words
2024-02-222023-12-310001104506-24-000008EDGAR88K words
2023-02-232022-12-310001104506-23-000009EDGAR88K words
2022-02-172021-12-310001104506-22-000008EDGAR—
2021-02-252020-12-310001104506-21-000005EDGAR—
2020-02-252019-12-310001104506-20-000007EDGAR—
2019-02-222018-12-310001104506-19-000009EDGAR—
2018-02-232017-12-310001104506-18-000002EDGAR—
2017-02-232016-12-310001047469-17-000856EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-062026-06-300001104506-26-000041EDGAR22K words
2026-05-072026-03-310001104506-26-000032EDGAR25K words
2025-10-302025-09-300001104506-25-000053EDGAR36K words
2025-08-072025-06-300001104506-25-000043EDGAR32K words
2025-05-082025-03-310001104506-25-000026EDGAR28K words
2024-10-312024-09-300001104506-24-000033EDGAR35K words
2024-08-082024-06-300001104506-24-000026EDGAR34K words
2024-05-092024-03-310001104506-24-000016EDGAR30K words
2023-10-262023-09-300001104506-23-000025EDGAR36K words
2023-08-032023-06-300001104506-23-000018EDGAR35K words
2023-05-042023-03-310001104506-23-000012EDGAR31K words
2022-10-272022-09-300001104506-22-000023EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-060001140361-26-031502EDGAR8K words
2026-07-160001140361-26-028602EDGAR5K words
2026-05-150001140361-26-021648EDGAR1K words
2026-05-070001140361-26-019430EDGAR7K words
2026-04-070001140361-26-013659EDGAR1K words
2026-03-230001140361-26-010651EDGAR4K words
2026-02-190001140361-26-006116EDGAR8K words
2026-01-090001140361-26-000778EDGAR5K words
2025-12-170001140361-25-045836EDGAR2K words
2025-11-180001140361-25-042598EDGAR2K words

208 total filings indexed. 176 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

respiratory-diseases immunology-and-inflammation neuro-and-other-rare-diseases non-cystic-fibrosis-bronchiectasis mac-lung-disease pulmonary-hypertension duchenne-muscular-dystrophy amyotrophic-lateral-sclerosis hidradenitis-suppurativa

Company Identity

CIK0001104506
TickerINSM
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedVA
Websitehttps://www.insmed.com
Listed2000-06-01

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: ba3400f20aa32d72c673212980cdfd3680399360aa992bbfeddf50134df8bd8e
parent: 55eba7e4d211b213e1b7189f72c961ca1da8ff3cce6aff22162640c52a67cf44
content hash: 71987bedc31c7bd57bb35d7c99656de3a784216cd272cdbf912a443a64c127ae
signed: 2026-09-29T19:01:45.236Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up INSM using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on INSM, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/INSM (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.